TechMARK movers: Antisoma gains on trial results

Related Companies

Related Indices

Related Sectors

News for Spread Betters

PreviousPrevious
NextNext

There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...

Get full details about Marketmaker:Investor Edition here. Advertisement

Date: Monday 07 Jul 2008

LONDON (ShareCast) - Initial findings from cancer drug developer Antisoma’s phase II trial of AS1411 in relapsed and refractory AML (acute myeloid leukaemia) have been well received today.

Patients are now being enrolled into a higher dose stage of the trial in patients with renal cancer, expected to start before the end of this year.

Financial software group Gresham Computing gave up some of Friday’s gains when it said that trading has improved “markedly” in the first six months and expects to report a “significantly improved result” for the period.

“We are working to continue this trend of improved results into the second half of 2008, delivering against a strong confirmed order book and prospect pipeline within our core real-time financial solutions business,” it said. The group said it continues to make solid progress with each of its core technologies.

“I am looking forward to us delivering some truly great solutions to our customers over the next six months and, as a result, an improved trading performance for 2008 and beyond,” added Gresham.

FTSE TechMARK - Risers
Antisoma (ASM) 22.00p +4.76%
Torotrak (TRK) 19.25p +2.67%
Sepura (SEPU) 75.00p +2.04%
Electronic Data Processing (EDP) 53.00p +1.92%
Psion (PON) 113.75p +1.56%
Indigo Vision (IND) 655.00p +1.55%
Alizyme (AZM) 18.25p +1.39%
Filtronic (FTC) 73.75p +1.03%
Imagination Technologies (IMG) 64.00p +0.79%
Vernalis (VER) 4.30p +0.47%

FTSE TechMARK - Fallers
Corin Group (CRG) 114.00p -9.16%
Anite Group (AIE) 37.50p -6.83%
Gresham Computing (GHT) 56.00p -5.08%
NCC Group (NCC) 362.00p -4.99%
Plasmon (PLM) 4.25p -4.49%
Vtech (VTH) 257.50p -3.74%
Fidessa (FDSA) 804.50p -3.19%
Elan Corporation (ELA) € 21.84 -2.85%
RM Group (RM.) 176.00p -2.76%
Axis-Shield (ASD) 287.00p -2.71%

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).